Ifp Advisors, Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 25,013 shares of ARWR stock, worth $486,502. This represents 0.03% of its overall portfolio holdings.

Number of Shares

25,013

Previous 25,013 -0.0%

Holding current value

$486,502

Previous $715,000 9.09%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	SELL	$27.21 - $39.48 $35,373 - $51,323	-1,300 Reduced 4.94%	25,013 $715,000
Q3 2023 Oct 12, 2023	BUY	$26.2 - $36.08 $89,368 - $123,068	3,411 Added 14.89%	26,313 $707,000
Q2 2023 Aug 04, 2023	SELL	$25.16 - $41.38 $94,375 - $155,216	-3,751 Reduced 14.07%	22,902 $816,000
Q1 2023 Apr 18, 2023	SELL	$23.68 - $38.51 $65,451 - $106,441	-2,764 Reduced 9.4%	26,653 $676,000
Q4 2022 Feb 07, 2023	BUY	$28.0 - $40.56 $135,996 - $196,999	4,857 Added 19.78%	29,417 $330,000
Q3 2022 Nov 08, 2022	BUY	$29.63 - $48.31 $22,844 - $37,247	771 Added 3.24%	24,560 $277,000
Q2 2022 Sep 06, 2022	BUY	$27.79 - $50.61 $661,096 - $1.2 Million	23,789 New	23,789 $267,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $661,096 - $1.2 Million	-23,789 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$39.62 - $69.97 $89,937 - $158,831	2,270 Added 10.55%	23,789 $1.09 Million
Q1 2022 Aug 08, 2022	BUY	$39.62 - $69.97 $1,465 - $2,588	37 Added 0.17%	21,519 $989,000
Q4 2021 Jan 12, 2022	BUY	$58.09 - $82.51 $4,066 - $5,775	70 Added 0.33%	21,482 $1.42 Million
Q3 2021 Oct 06, 2021	BUY	$58.38 - $84.96 $30,182 - $43,924	517 Added 2.47%	21,412 $1.34 Million
Q2 2021 Jul 13, 2021	BUY	$62.15 - $90.32 $148,662 - $216,045	2,392 Added 12.93%	20,895 $1.73 Million
Q1 2021 Apr 30, 2021	SELL	$61.35 - $90.47 $5,828 - $8,594	-95 Reduced 0.51%	18,503 $1.23 Million
Q4 2020 Jan 25, 2021	SELL	$43.82 - $85.37 $40,489 - $78,881	-924 Reduced 4.73%	18,598 $1.43 Million
Q3 2020 Oct 29, 2020	BUY	$33.21 - $51.27 $30,984 - $47,834	933 Added 5.02%	19,522 $840,000
Q2 2020 Aug 05, 2020	BUY	$26.12 - $43.27 $36,097 - $59,799	1,382 Added 8.03%	18,589 $794,000
Q1 2020 May 12, 2020	BUY	$20.56 - $63.12 $80,389 - $246,799	3,910 Added 29.41%	17,207 $529,000
Q4 2019 Jan 17, 2020	SELL	$28.14 - $73.01 $157,555 - $408,782	-5,599 Reduced 29.63%	13,297 $864,000
Q3 2019 Nov 07, 2019	BUY	$26.26 - $34.86 $496,208 - $658,714	18,896 New	18,896 $508,000
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $219,502 - $367,598	-18,216 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$10.74 - $19.7 $163,419 - $299,755	15,216 Added 507.2%	18,216 $226,000
Q3 2018 Oct 25, 2018	BUY	$14.0 - $20.3 $21,000 - $30,450	1,500 Added 100.0%	3,000 $0
Q2 2018 Aug 07, 2018	SELL	$6.37 - $14.02 $2,548 - $5,608	-400 Reduced 21.05%	1,500 $0
Q2 2016 Jun 03, 2019	BUY	N/A	1,900	1,900 $10,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.06B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account